Global Prostate Cancer Diagnostics and Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Diagnostics and Therapy Market Size 2017-2028

2.1.2 Prostate Cancer Diagnostics and Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Prostate Cancer Diagnostics and Therapy Segment by Treatment Method

2.2.1 Androgen Receptor-Directed Therapy

2.2.2 Taxane-Based Chemotherapy

2.3 Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method

2.3.1 Prostate Cancer Diagnostics and Therapy Market Size CAGR by Treatment Method (2017 VS 2022 VS 2028)

2.3.2 Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

2.4 Prostate Cancer Diagnostics and Therapy Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Prostate Cancer Diagnostics and Therapy Market Size by Application

2.5.1 Prostate Cancer Diagnostics and Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

3 Prostate Cancer Diagnostics and Therapy Market Size by Player

3.1 Prostate Cancer Diagnostics and Therapy Market Size Market Share by Players

3.1.1 Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2020-2022)

3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Prostate Cancer Diagnostics and Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Prostate Cancer Diagnostics and Therapy by Regions

4.1 Prostate Cancer Diagnostics and Therapy Market Size by Regions (2017-2022)

4.2 Americas Prostate Cancer Diagnostics and Therapy Market Size Growth (2017-2022)

4.3 APAC Prostate Cancer Diagnostics and Therapy Market Size Growth (2017-2022)

4.4 Europe Prostate Cancer Diagnostics and Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)

5.2 Americas Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)

5.3 Americas Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022)

6.2 APAC Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)

6.3 APAC Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Prostate Cancer Diagnostics and Therapy by Country (2017-2022)

7.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)

7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy by Region (2017-2022)

8.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)

8.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Prostate Cancer Diagnostics and Therapy Market Forecast

10.1 Global Prostate Cancer Diagnostics and Therapy Forecast by Regions (2023-2028)

10.1.1 Global Prostate Cancer Diagnostics and Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Prostate Cancer Diagnostics and Therapy Forecast

10.1.3 APAC Prostate Cancer Diagnostics and Therapy Forecast

10.1.4 Europe Prostate Cancer Diagnostics and Therapy Forecast

10.1.5 Middle East & Africa Prostate Cancer Diagnostics and Therapy Forecast

10.2 Americas Prostate Cancer Diagnostics and Therapy Forecast by Country (2023-2028)

10.2.1 United States Prostate Cancer Diagnostics and Therapy Market Forecast

10.2.2 Canada Prostate Cancer Diagnostics and Therapy Market Forecast

10.2.3 Mexico Prostate Cancer Diagnostics and Therapy Market Forecast

10.2.4 Brazil Prostate Cancer Diagnostics and Therapy Market Forecast

10.3 APAC Prostate Cancer Diagnostics and Therapy Forecast by Region (2023-2028)

10.3.1 China Prostate Cancer Diagnostics and Therapy Market Forecast

10.3.2 Japan Prostate Cancer Diagnostics and Therapy Market Forecast

10.3.3 Korea Prostate Cancer Diagnostics and Therapy Market Forecast

10.3.4 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Forecast

10.3.5 India Prostate Cancer Diagnostics and Therapy Market Forecast

10.3.6 Australia Prostate Cancer Diagnostics and Therapy Market Forecast

10.4 Europe Prostate Cancer Diagnostics and Therapy Forecast by Country (2023-2028)

10.4.1 Germany Prostate Cancer Diagnostics and Therapy Market Forecast

10.4.2 France Prostate Cancer Diagnostics and Therapy Market Forecast

10.4.3 UK Prostate Cancer Diagnostics and Therapy Market Forecast

10.4.4 Italy Prostate Cancer Diagnostics and Therapy Market Forecast

10.4.5 Russia Prostate Cancer Diagnostics and Therapy Market Forecast

10.5 Middle East & Africa Prostate Cancer Diagnostics and Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Prostate Cancer Diagnostics and Therapy Market Forecast

10.5.2 South Africa Prostate Cancer Diagnostics and Therapy Market Forecast

10.5.3 Israel Prostate Cancer Diagnostics and Therapy Market Forecast

10.5.4 Turkey Prostate Cancer Diagnostics and Therapy Market Forecast

10.5.5 GCC Countries Prostate Cancer Diagnostics and Therapy Market Forecast

10.6 Global Prostate Cancer Diagnostics and Therapy Forecast by Treatment Method (2023-2028)

10.7 Global Prostate Cancer Diagnostics and Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Ipsen SA

11.1.1 Ipsen SA Company Information

11.1.2 Ipsen SA Prostate Cancer Diagnostics and Therapy Product Offered

11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Ipsen SA Main Business Overview

11.1.5 Ipsen SA Latest Developments

11.2 Pfizer Inc.

11.2.1 Pfizer Inc. Company Information

11.2.2 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Inc. Main Business Overview

11.2.5 Pfizer Inc. Latest Developments

11.3 Johnson & Johnson Services Inc.

11.3.1 Johnson & Johnson Services Inc. Company Information

11.3.2 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Johnson & Johnson Services Inc. Main Business Overview

11.3.5 Johnson & Johnson Services Inc. Latest Developments

11.4 Bayer AG

11.4.1 Bayer AG Company Information

11.4.2 Bayer AG Prostate Cancer Diagnostics and Therapy Product Offered

11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bayer AG Main Business Overview

11.4.5 Bayer AG Latest Developments

11.5 Abbvie Inc.

11.5.1 Abbvie Inc. Company Information

11.5.2 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Abbvie Inc. Main Business Overview

11.5.5 Abbvie Inc. Latest Developments

11.6 Merck & Co. Inc.

11.6.1 Merck & Co. Inc. Company Information

11.6.2 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Merck & Co. Inc. Main Business Overview

11.6.5 Merck & Co. Inc. Latest Developments

11.7 AstraZeneca PLC

11.7.1 AstraZeneca PLC Company Information

11.7.2 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product Offered

11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 AstraZeneca PLC Main Business Overview

11.7.5 AstraZeneca PLC Latest Developments

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Information

11.8.2 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product Offered

11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Thermo Fisher Scientific Main Business Overview

11.8.5 Thermo Fisher Scientific Latest Developments

11.9 Dendreon Pharmaceuticals LLC

11.9.1 Dendreon Pharmaceuticals LLC Company Information

11.9.2 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product Offered

11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Dendreon Pharmaceuticals LLC Main Business Overview

11.9.5 Dendreon Pharmaceuticals LLC Latest Developments

11.10 F. Hoffmann-La Roche Ltd

11.10.1 F. Hoffmann-La Roche Ltd Company Information

11.10.2 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product Offered

11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.10.5 F. Hoffmann-La Roche Ltd Latest Developments

11.11 Hologic Inc.

11.11.1 Hologic Inc. Company Information

11.11.2 Hologic Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Hologic Inc. Main Business Overview

11.11.5 Hologic Inc. Latest Developments

11.12 Astellas Pharma Inc.

11.12.1 Astellas Pharma Inc. Company Information

11.12.2 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product Offered

11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Astellas Pharma Inc. Main Business Overview

11.12.5 Astellas Pharma Inc. Latest Developments

11.13 Koninklijke Philips NV

11.13.1 Koninklijke Philips NV Company Information

11.13.2 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product Offered

11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Koninklijke Philips NV Main Business Overview

11.13.5 Koninklijke Philips NV Latest Developments

11.14 Sanofi-Aventis

11.14.1 Sanofi-Aventis Company Information

11.14.2 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product Offered

11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Sanofi-Aventis Main Business Overview

11.14.5 Sanofi-Aventis Latest Developments

12 Research Findings and Conclusion

Table 1. Prostate Cancer Diagnostics and Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Androgen Receptor-Directed Therapy

Table 3. Major Players of Taxane-Based Chemotherapy

Table 4. Prostate Cancer Diagnostics and Therapy Market Size CAGR by Treatment Method (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 6. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 7. Prostate Cancer Diagnostics and Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

Table 10. Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Player (2020-2022)

Table 12. Prostate Cancer Diagnostics and Therapy Key Players Head office and Products Offered

Table 13. Prostate Cancer Diagnostics and Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Prostate Cancer Diagnostics and Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Regions (2017-2022)

Table 18. Americas Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Prostate Cancer Diagnostics and Therapy Market Size Market Share by Country (2017-2022)

Table 20. Americas Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 21. Americas Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 22. Americas Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

Table 24. APAC Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Prostate Cancer Diagnostics and Therapy Market Size Market Share by Region (2017-2022)

Table 26. APAC Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 27. APAC Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 28. APAC Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

Table 30. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Country (2017-2022)

Table 32. Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 33. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 34. Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 40. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Prostate Cancer Diagnostics and Therapy

Table 43. Key Market Challenges & Risks of Prostate Cancer Diagnostics and Therapy

Table 44. Key Industry Trends of Prostate Cancer Diagnostics and Therapy

Table 45. Global Prostate Cancer Diagnostics and Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Prostate Cancer Diagnostics and Therapy Market Size Forecast by Treatment Method (2023-2028) & ($ Millions)

Table 48. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share Forecast by Treatment Method (2023-2028)

Table 49. Global Prostate Cancer Diagnostics and Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 51. Ipsen SA Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 52. Ipsen SA Prostate Cancer Diagnostics and Therapy Product Offered

Table 53. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Ipsen SA Main Business

Table 55. Ipsen SA Latest Developments

Table 56. Pfizer Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 57. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 58. Pfizer Inc. Main Business

Table 59. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Pfizer Inc. Latest Developments

Table 61. Johnson & Johnson Services Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 62. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 63. Johnson & Johnson Services Inc. Main Business

Table 64. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Johnson & Johnson Services Inc. Latest Developments

Table 66. Bayer AG Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 67. Bayer AG Prostate Cancer Diagnostics and Therapy Product Offered

Table 68. Bayer AG Main Business

Table 69. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Bayer AG Latest Developments

Table 71. Abbvie Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 72. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 73. Abbvie Inc. Main Business

Table 74. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Abbvie Inc. Latest Developments

Table 76. Merck & Co. Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 77. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 78. Merck & Co. Inc. Main Business

Table 79. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Merck & Co. Inc. Latest Developments

Table 81. AstraZeneca PLC Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 82. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product Offered

Table 83. AstraZeneca PLC Main Business

Table 84. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. AstraZeneca PLC Latest Developments

Table 86. Thermo Fisher Scientific Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 87. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product Offered

Table 88. Thermo Fisher Scientific Main Business

Table 89. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Thermo Fisher Scientific Latest Developments

Table 91. Dendreon Pharmaceuticals LLC Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 92. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product Offered

Table 93. Dendreon Pharmaceuticals LLC Main Business

Table 94. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Dendreon Pharmaceuticals LLC Latest Developments

Table 96. F. Hoffmann-La Roche Ltd Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 97. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product Offered

Table 98. F. Hoffmann-La Roche Ltd Main Business

Table 99. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. F. Hoffmann-La Roche Ltd Latest Developments

Table 101. Hologic Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 102. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 103. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Hologic Inc. Main Business

Table 105. Hologic Inc. Latest Developments

Table 106. Astellas Pharma Inc. Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 107. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product Offered

Table 108. Astellas Pharma Inc. Main Business

Table 109. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Astellas Pharma Inc. Latest Developments

Table 111. Koninklijke Philips NV Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 112. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product Offered

Table 113. Koninklijke Philips NV Main Business

Table 114. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Koninklijke Philips NV Latest Developments

Table 116. Sanofi-Aventis Details, Company Type, Prostate Cancer Diagnostics and Therapy Area Served and Its Competitors

Table 117. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product Offered

Table 118. Sanofi-Aventis Main Business

Table 119. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Sanofi-Aventis Latest Developments

List of Figures

Figure 1. Prostate Cancer Diagnostics and Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method in 2021

Figure 7. Prostate Cancer Diagnostics and Therapy in Hospitals

Figure 8. Global Prostate Cancer Diagnostics and Therapy Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Prostate Cancer Diagnostics and Therapy in Clinics

Figure 10. Global Prostate Cancer Diagnostics and Therapy Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Prostate Cancer Diagnostics and Therapy in Others

Figure 12. Global Prostate Cancer Diagnostics and Therapy Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application in 2021

Figure 14. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Player in 2021

Figure 15. Global Prostate Cancer Diagnostics and Therapy Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Prostate Cancer Diagnostics and Therapy Market Size 2017-2022 ($ Millions)

Figure 17. APAC Prostate Cancer Diagnostics and Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Europe Prostate Cancer Diagnostics and Therapy Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Americas Prostate Cancer Diagnostics and Therapy Value Market Share by Country in 2021

Figure 21. Americas Prostate Cancer Diagnostics and Therapy Consumption Market Share by Treatment Method in 2021

Figure 22. Americas Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application in 2021

Figure 23. United States Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Prostate Cancer Diagnostics and Therapy Market Size Market Share by Region in 2021

Figure 28. APAC Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application in 2021

Figure 29. China Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Country in 2021

Figure 36. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method in 2021

Figure 37. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application in 2021

Figure 38. Germany Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method in 2021

Figure 45. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application in 2021

Figure 46. Egypt Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Prostate Cancer Diagnostics and Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 52. APAC Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 53. Europe Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 55. United States Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Canada Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 59. China Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Japan Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Korea Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 63. India Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Australia Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Germany Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 66. France Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 67. UK Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Italy Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Russia Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Spain Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Israel Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Prostate Cancer Diagnostics and Therapy Market Size 2023-2028 ($ Millions)